Hite Christopherinsider trades

In SEC Form 4 filings, Hite Christopher is listed as EVP & Chairman, Partnering of Royalty Pharma plc (RPRX). In the last 90 days, Hite Christopher sold $5.85M of Royalty Pharma plc (RPRX) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
RPRXRoyalty Pharma plc	EVP & Chairman, Partnering	2	Sep 24

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-24

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
RPRXRoyalty Pharma plc	Sep 22	Sep 24	S	96,073	$58.51	Sale −$5,621,692	274,328	Yes	Form 4
RPRXRoyalty Pharma plc	Sep 22	Sep 24	S	3,927	$58.93	Sale −$231,403	270,401	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.